Vous êtes sur la page 1sur 3

PRODUTOS FARMACÊUTICOS

Exportações Brasileiras - Em US$ FOB


Por Posições do Capítulo 30 da NCM
Período: 2000 a 2009*

NCM 2000 % 2001 % 2002 % 2003 % 2004 % 2005 % 2006 %


30.01 13,530,200 6.2% 10,746,507 4.4% 9,097,127 3.6% 9,218,980 3.3% 9,914,938 2.8% 14,856,627 3.1% 17,493,671 2.8%
30.02 9,391,894 4.3% 16,901,385 7.0% 15,761,525 6.2% 22,544,148 8.0% 35,396,702 10.0% 31,967,202 6.7% 30,198,586 4.9%
30.03 5,610,757 2.6% 2,657,592 1.1% 2,731,919 1.1% 4,394,052 1.6% 3,465,877 1.0% 2,513,416 0.5% 4,314,157 0.7%
30.04 146,882,152 67.1% 165,782,424 68.5% 181,382,277 71.4% 197,623,771 70.4% 234,570,019 66.5% 309,048,376 65.1% 437,794,470 70.4%
30.05 2,225,452 1.0% 2,921,745 1.2% 2,665,908 1.0% 4,596,647 1.6% 27,668,640 7.8% 65,436,438 13.8% 68,021,046 10.9%
30.06 41,254,259 18.8% 42,848,237 17.7% 42,278,930 16.7% 42,371,399 15.1% 41,603,190 11.8% 50,672,408 10.7% 64,306,760 10.3%
TOTAL 218,894,714 100% 241,857,890 100% 253,917,686 100% 280,748,997 100.0% 352,619,366 100% 474,494,467 100% 622,128,690 100.0%

(*) Período: Janeiro a Fevereiro de 2009


Obs.: Dados sujeitos à retificação

Fonte: MDIC/Secex/Sistema Alice


Elaboração: FEBRAFARMA/Depto. de Economia
LAD/
2007 % 2008 % 2009* %
10,935,608 1.5% 12,321,485 1.3% 1,901,125 1.3%
46,458,935 6.2% 61,808,476 6.4% 9,435,387 6.3%
8,336,426 1.1% 10,522,005 1.1% 1,304,788 0.9%
510,068,220 68.4% 656,699,770 68.3% 105,538,513 71.0%
82,854,311 11.1% 80,722,937 8.4% 11,192,502 7.5%
87,018,312 11.7% 139,381,803 14.5% 19,369,659 13.0%
745,671,812 100.0% 961,456,476 100.0% 148,741,974 100.0%
Valores em US$ FOB PRODUTOS FARMACÊUTICOS - CAPÍTULO 30 DA NCM
Evolução das Exportações Brasileiras - Em US$ FOB
Período: 2000 a 2009*
1,000,000,000
950,000,000
900,000,000
850,000,000
800,000,000
750,000,000
700,000,000
650,000,000
600,000,000
550,000,000
500,000,000
450,000,000
400,000,000
350,000,000
300,000,000
250,000,000
200,000,000
150,000,000
100,000,000
50,000,000
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009*
Fonte: MDIC/Secex/Sistema Alice
*Período: Jan a Fev de 2009
Elaboração: FEBRAFARMA/Depto. de Economia

Vous aimerez peut-être aussi